The global intragastric balloons market is poised for substantial growth through 2031, driven by rising obesity prevalence, increasing awareness of non-surgical weight management solutions, and advancements in endoscopic technologies. Valued at US$ 55.5 Mn in 2022, the industry is projected to expand at a robust CAGR of 12.2% from 2023 to 2031, reaching an estimated US$ 160.7 Mn by the end of the forecast period. As healthcare systems worldwide intensify efforts to address obesity-related comorbidities such as diabetes, cardiovascular diseases, and metabolic disorders, intragastric balloons are emerging as a preferred minimally invasive intervention, particularly among patients who are not candidates for bariatric surgery.
Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26006
Market Overview
Intragastric balloons are saline- or gas-filled medical devices placed in the stomach endoscopically to induce a feeling of fullness, thereby reducing food intake and promoting weight loss. Unlike permanent surgical procedures, these devices are temporary and typically removed after six months to one year. Growing patient preference for reversible and non-surgical treatments has significantly enhanced market penetration. Furthermore, technological innovations such as swallowable balloons that eliminate the need for endoscopy during placement are reshaping the competitive landscape and broadening patient accessibility.
The growing global burden of obesity remains the primary growth driver. According to health agencies, obesity rates continue to rise across developed and emerging economies, creating a sustained demand for effective and safe weight-loss interventions. Additionally, improvements in reimbursement frameworks in select countries and increasing physician awareness are expected to support market expansion.
Market Size and Growth
The market’s valuation of US$ 55.5 Mn in 2022 reflects steady adoption across North America and Europe. However, the forecasted growth to US$ 160.7 Mn by 2031 underscores accelerating demand in Asia-Pacific and Latin America. The projected CAGR of 12.2% highlights strong investor confidence and innovation momentum within the industry. Key factors contributing to this growth include rising disposable income, expanding medical tourism, and growing acceptance of minimally invasive cosmetic and metabolic procedures.
Market Segmentation
The intragastric balloons market can be segmented by product type, filling material, end-user, and region. By product type, the market includes single balloons, dual balloons, and swallowable balloon systems. Dual balloon systems are gaining traction due to improved stability and reduced migration risk. Based on filling material, saline-filled balloons dominate the market, though gas-filled and newer swallowable variants are expanding rapidly due to improved patient comfort and reduced procedural complexity.
In terms of end-users, hospitals and specialty clinics represent the largest segment, driven by access to advanced endoscopic facilities and experienced practitioners. Ambulatory surgical centers are also witnessing growth as outpatient procedures become more common.
Regional Analysis
North America currently leads the global intragastric balloons market due to high obesity rates, favorable reimbursement scenarios, and strong presence of established manufacturers. Europe follows closely, supported by increasing adoption of non-surgical weight-loss procedures and growing healthcare expenditure.
Asia-Pacific is expected to register the fastest growth during the forecast period, fueled by rising obesity awareness, expanding middle-class populations, and improving healthcare infrastructure in countries such as China and India. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as promising markets, supported by medical tourism and growing aesthetic procedure demand.
Competitive Landscape
The global market is moderately consolidated, with several key players driving innovation and strategic expansion. Prominent companies include Apollo Endosurgery, Inc., ReShape Lifesciences, Inc., Spatz FGIA, Inc., Allurion S.a.s., ENDALIS, Helioscopie, LEXEL S.R.L., and CSC MEDSIL. These players are focusing on product innovation, regulatory approvals, geographic expansion, and strategic partnerships to strengthen their global footprint. The introduction of swallowable balloon capsules and adjustable balloon systems represents a significant competitive differentiator.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Comments (0)